Home > Insider Trading > Filing (0001209191-10-018094)

Filing Details

Accession Number:: 0001209191-10-018094
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-22 13:00:00
Reporting Period:: 2010-03-18

Filing Date:: 2010-03-22
Accepted Time:: 2010-03-22 06:04:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339455	Somaxon Pharmaceuticals Inc.	SOMX	Pharmaceutical Preparations (2834)	200161599

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380762	Brian Dorsey	C/O Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130	Vp Product Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2010-03-18	5,580	$3.94	21,920	No	4	F	Direct
Common Stock	Disposition	2010-03-18	8,100	$6.61	13,820	No	4	S	Direct
Common Stock	Disposition	2010-03-18	2,100	$7.89	11,720	No	4	S	Direct
Common Stock	Disposition	2010-03-18	1,800	$8.91	9,920	No	4	S	Direct
Common Stock	Disposition	2010-03-18	500	$9.75	9,420	No	4	S	Direct
Common Stock	Acquisiton	2010-03-18	25,542	$1.23	34,962	No	4	M	Direct
Common Stock	Acquisiton	2010-03-18	32,458	$1.23	67,420	No	4	M	Direct
Common Stock	Disposition	2010-03-18	23,000	$5.23	44,420	No	4	S	Direct
Common Stock	Disposition	2010-03-18	15,800	$6.67	28,620	No	4	S	Direct
Common Stock	Disposition	2010-03-18	15,900	$7.92	12,720	No	4	S	Direct
Common Stock	Disposition	2010-03-18	2,800	$8.78	9,920	No	4	S	Direct
Common Stock	Disposition	2010-03-18	500	$9.74	9,420	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2010-03-18	25,542	$0.00	25,542	$1.23
Common Stock	Employee Stock Option (right to buy)	Disposition	2010-03-18	32,458	$0.00	32,458	$1.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,839		2018-02-18	No	4	M	Direct
50,875		2019-02-16	No	4	M	Direct

Footnotes

Pursuant to the terms of a Restricted Stock Award Agreement dated as of October 8, 2007 between the reporting person and the issuer, the reporting person is transferring the shares to the issuer to meet the reporting person's obligation to pay to the issuer the tax that the issuer is required to withhold in connection with the vesting of 15,000 shares of restricted stock.
This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, with the proceeds remitted to the Company to cover the taxes withheld upon the vesting of 15,000 restricted stock units on March 18, 2010.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.24 to $7.23 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.35 to $8.21 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.47 to $9.30 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.61 to $9.84 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 trading plan adopted by the reporting person in 2009.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $5.10 to $5.29 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.24 to $7.24 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.31 to $8.17 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.39 to $9.2256 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
1/3 of the shares of Common Stock subject to this grant vested on the date of grant (June 9, 2009) and the remaining shaes will vest and become exercisable in 24 equal monthly installments over the following two-year period.
Not applicable.